These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26591164)

  • 21. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.
    Kim KJ; Baek IW; Park YJ; Yoon CH; Kim WU; Cho CS
    Int J Rheum Dis; 2015 Jun; 18(5):524-32. PubMed ID: 24428867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
    Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
    J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory.
    Mader R; Ziporen L; Mader R; Neumann L; Buskila D
    Clin Rheumatol; 2002 Sep; 21(5):386-90. PubMed ID: 12223987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
    Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H
    Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus (SLE) in the eastern region of Saudi Arabia. A comparative study.
    Abid N; Khan AS; Al Otaibi FH
    Lupus; 2013 Dec; 22(14):1529-33. PubMed ID: 23934402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations.
    Anuardo P; Verdier M; Gormezano NW; Ferreira GR; Leal GN; Lianza A; Ferreira JC; Pereira RM; Aikawa NE; Terreri MT; Magalhães CS; Appenzeller S; Dos Santos MC; Sachetti SB; Len CA; Pilleggi GS; Lotufo S; Bonfá E; Silva CA
    Pediatr Cardiol; 2017 Feb; 38(2):234-239. PubMed ID: 27826712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid antibodies--our experience.
    Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
    Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
    Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
    Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.
    Dayama A; Dass J; Mahapatra M; Saxena R
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):657-662. PubMed ID: 27067744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in apolipoprotein H (beta2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus.
    Kamboh MI; Manzi S; Mehdi H; Fitzgerald S; Sanghera DK; Kuller LH; Atson CE
    Lupus; 1999; 8(9):742-50. PubMed ID: 10602447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.
    Lundström E; Gustafsson JT; Jönsen A; Leonard D; Zickert A; Elvin K; Sturfelt G; Nordmark G; Bengtsson AA; Sundin U; Källberg H; Sandling JK; Syvänen AC; Klareskog L; Gunnarsson I; Rönnblom L; Padyukov L; Svenungsson E
    Ann Rheum Dis; 2013 Jun; 72(6):1018-25. PubMed ID: 22893315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.